Kent Edward Kester serves as Executive at Turn Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Kent Edward Kester has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 8, 2025 involved receiving (via award) 10,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 8, 2025 | TTRX | $0 | Award | 10,000 | $N/A | Discretionary |
Kent Edward Kester currently holds 10,000 shares of Turn Therapeutics Inc. (TTRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kent Edward Kester has been a net neutral trader of TTRX stock. They have purchased $0 and sold $0 worth of shares.
Kent Edward Kester's most recent insider trade was on Oct 8, 2025, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted